Search Results - "Miao, Raymond"

Taxane chemotherapy vs antiandrogen agents as first‐line therapy for metastatic castration‐resistant prostate cancer by Sonpavde, Guru, Huang, Ahong, Wang, Li, Baser, Onur, Miao, Raymond

“…Objectives To assess treatment patterns and outcomes of patients with metastatic castration‐resistant prostate cancer (mCRPC) receiving first‐line chemotherapy…”
Get full text

Real-world utilization patterns of systemic immunosuppressants among US adult patients with atopic dermatitis by Armstrong, April W, Huang, Ahong, Wang, Li, Miao, Raymond, Patel, Miraj Y, Gadkari, Abhijit, Mallya, Usha G, Chao, Jingdong

“…At the time of this study, prior to the introduction of biologics in the US, systemic therapies used for the treatment of moderate-to-severe atopic dermatitis…”
Get full text

Real-world characteristics and outcomes of patients with metastatic castration-resistant prostate cancer receiving chemotherapy versus androgen receptor-targeted therapy after failure of first-line androgen receptor-targeted therapy in the community setting by Oh, William K., MD, Miao, Raymond, MS, Vekeman, Francis, MA, Sung, Jennifer, PharmD, MSc, MBA, Cheng, Wendy Y., MPH, MPhil, Gauthier-Loiselle, Marjolaine, PhD, Dhawan, Ravinder, PhD, Duh, Mei Sheng, ScD, MPH

“…Abstract Background In metastatic castration-resistant prostate cancer (mCRPC), optimal treatment sequences are unknown. We assessed second-line taxane (TT)…”
Get full text

Higher Incidence of Venous Thromboembolism in the Outpatient Versus the Inpatient Setting Among U.S. Cancer Patients by Khorana, Alok A, Dalal, Mehul, Tangirala, Krishna, Miao, Raymond

“…Abstract 674 Paradigm changes in cancer therapy have shifted care to primarily outpatient-based regimens. Venous thromboembolism (VTE) is a well-known…”
Get full text

Burden of Atopic Dermatitis in the United States: Analysis of Healthcare Claims Data in the Commercial, Medicare, and Medi-Cal Databases by Shrestha, Sulena, Miao, Raymond, Wang, Li, Chao, Jingdong, Yuce, Huseyin, Wei, Wenhui

“…Introduction Comparative data on the burden of atopic dermatitis (AD) in adults relative to the general population are limited. We performed a large-scale…”
Get full text

First-line chemotherapy (CT) versus anti-androgen therapy (AT) for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Individual patient analysis of the Veterans Health Administration (VHA) dataset by Sonpavde, Guru, Huang, Ahong, Wang, Li, Baser, Onur, Miao, Raymond

“…Abstract only 156 Background: The outcomes of pts receiving first-line CT vs AT for mCRPC are unclear. Using the VHA dataset, we compared outcomes with…”
Get full text

Treatment patterns of pediatric patients with atopic dermatitis: A claims data analysis by Paller, Amy S., Siegfried, Elaine C., Vekeman, Francis, Gadkari, Abhijit, Kaur, Mandeep, Mallya, Usha G., Héroux, Julie, Miao, Raymond, Mina-Osorio, Paola

“…Real-world evidence on treatment patterns of pediatric patients with atopic dermatitis (AD) is sparse. To assess current treatment patterns in pediatric AD…”
Get full text

Real-world outcomes in patients with metastatic castration-resistant prostate cancer receiving second-line chemotherapy versus an alternative androgen receptor-targeted agent (ARTA) following early progression on a first-line ARTA in a US community oncology setting by Oh, William K., Cheng, Wendy Y., Miao, Raymond, Vekeman, Francis, Gauthier-Loiselle, Marjolaine, Duh, Mei Sheng, Drea, Edward, Szatrowski, Ted P.

“…•This study compared second-line treatment outcomes in patients with mCRCaP.•Evaluable patients progressed within 12 months of first-line ARTA…”
Get full text

Real-world outcomes of US employees with type 2 diabetes mellitus treated with insulin glargine or neutral protamine Hagedorn insulin: a comparative retrospective database study by Wang, Li, Wei, Wenhui, Miao, Raymond, Xie, Lin, Baser, Onur

“…Objectives To compare real-world outcomes of initiating insulin glargine (GLA) versus neutral protamine Hagedorn (NPH) insulin among employees with type 2…”
Get full text

Sequencing of chemotherapy and androgen-axis inhibitors (AAIs) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) by Dhawan, Ravinder, Yang, Tony, Miao, Raymond, Hennessy, Daniel, Sonpavde, Guru

“…Abstract only…”
Get full text

30-Day Readmission Among Elderly Medicare Beneficiaries with Type 2 Diabetes by Raval, Amit D, Zhou, Steve, Wei, Wenhui, Bhattacharjee, Sandipan, Miao, Raymond, Sambamoorthi, Usha

“…This study retrospectively assessed rates and risk factors for all-cause hospital readmission among elderly Medicare beneficiaries with type 2 diabetes…”
Get more information

Budgetary Impact of Cabazitaxel Use After Docetaxel Treatment for Metastatic Castration-Resistant Prostate Cancer by Flannery, Kyle, Drea, Ed, Hudspeth, Louis, Corman, Shelby, Gao, Xin, Xue, Mei, Miao, Raymond

“…With the approval of several new treatments for metastatic castration-resistant prostate cancer (mCRPC), budgetary impact is a concern for health plan decision…”
Get full text

Retrospective study of treatment outcomes among metastatic castration-resistant prostate cancer patients receiving cabazitaxel and/or enzalutamide in later lines of therapy by Hirsch, Bradford R, Miao, Raymond, Hudspeth, Louis, Wang, Hong, Payne, Debra, McCormick, John

“…Abstract only…”
Get full text

Effects of variations in access to care for children with atopic dermatitis by Siegfried, Elaine C, Paller, Amy S, Mina-Osorio, Paola, Vekeman, Francis, Kaur, Mandeep, Mallya, Usha G, Héroux, Julie, Miao, Raymond, Gadkari, Abhijit

“…An estimated 50% of children in the US are Medicaid-insured. Some of these patients have poor health literacy and limited access to medications and specialty…”
Get full text

Real-world outcomes in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving second-line (2L) chemotherapy (CT) vs alternative androgen receptor-targeted agents (ARTA) after lack of response to first-line (1L) ARTA in US community oncology practices by Oh, William K., Cheng, Wendy Y., Miao, Raymond, Vekeman, Francis, Gauthier-Loiselle, Marjolaine, Duh, Mei Sheng, Drea, Edward, Szatrowski, Ted P.

“…Abstract only 214 Background: The relationship between treatment sequence and mCRPC outcomes is unclear. This retrospective study assessed if 2L CT vs…”
Get full text

Patient characteristics and overall survival in patients with post-docetaxel metastatic castration-resistant prostate cancer in the community setting by Oh, William K., Miao, Raymond, Vekeman, Francis, Sung, Jennifer, Cheng, Wendy Y., Gauthier-Loiselle, Marjolaine, Dhawan, Ravinder, Duh, Mei Sheng

“…It is unclear how treatment sequencing for metastatic castration-resistant prostate cancer (mCRPC) affects real-world patient outcomes. We assessed treatment…”
Get full text

Utilization patterns of abiraterone acetate before and after chemotherapy in patients with metastatic castration-resistant prostate cancer in the Veterans Health Administration System by Brixner, Diana I., Dhawan, Ravinder, Miao, Raymond, Sung, Jennifer, Wang, Li, Baser, Onur, Mehta, Jyotsna

“…Abstract only…”
Get full text

Much Ado About Nothing? A Real-World Study of Patients with Type 2 Diabetes Switching Basal Insulin Analogs by Wei, Wenhui, Zhou, Steve, Miao, Raymond, Pan, Chunshen, Xie, Lin, Baser, Onur, Gill, Jasvinder

“…Introduction Type-2 diabetes mellitus (T2DM) is a progressive disease, and many patients eventually require insulin therapy. This study examined real-world…”
Get full text

Clinical features and overall survival (OS) in patients (pts) with post-docetaxel (DTX) metastatic castration-resistant prostate cancer (mCRPC) receiving second-line (2L) therapy in the community setting by Oh, William K., Miao, Raymond, Duh, Mei Sheng, Vekeman, Francis, Sung, Jennifer, Cheng, Wendy Y, Hennessy, Daniel, Gauthier-Loiselle, Marjolaine, Fortier, Jonathan, Dhawan, Ravinder

“…Abstract only…”
Get full text

Does Device Make Any Difference? A Real-world Retrospective Study of Insulin Treatment Among Elderly Patients With Type 2 Diabetes by Miao, Raymond, Wei, Wenhui, Lin, Jay, Xie, Lin, Baser, Onur

“…Background: We compared real-world clinical and economic outcomes for insulin glargine treatment administered by disposable pen and traditional…”
Get full text